Emily Ann Rafferty - 03 Jul 2023 Form 3 Insider Report for Evolent Health, Inc. (EVH)

Role
Chief Operating Officer
Signature
/s/ Jonathan Weinberg, Attorney-in-fact
Issuer symbol
EVH
Transactions as of
03 Jul 2023
Net transactions value
$0
Form type
3
Filing time
13 Jul 2023, 16:43:25 UTC
Next filing
17 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding EVH Class A Common Stock 78,797 03 Jul 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding EVH Class A Common Option (right to buy) 03 Jul 2023 Class A Common Stock 9,191 $18.25 Direct F2
holding EVH Class A Common Option (right to buy) 03 Jul 2023 Class A Common Stock 16,835 $13.95 Direct F3
holding EVH Class A Common Option (right to buy) 03 Jul 2023 Class A Common Stock 14,368 $13.29 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes restricted stock units granted to Ms. Rafferty pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
F2 9,191 options were granted on February 1, 2017 and vested and became exercisable ratably in four annual installments beginning on February 1, 2018.
F3 16,835 options were granted on February 1, 2018 and vested and became exercisable ratably in four annual installments beginning on February 1, 2019.
F4 14,368 options were granted on March 1, 2019 and vested and became exercisable ratably in four annual installments beginning on March 1, 2020.

Remarks:

See Exhibit 24.1 - Power of Attorney